Agios Crashes 19% After A Surprise Side Effect Hammered Its 'Very Safe' Drug
Shares of Agios Pharmaceuticals collapsed Monday on an unexpected side effect related to the company's thalassemia treatment, mitapivat. The post Agios Crashes 19% After A Surprise Side Effect Hammered Its 'Very Safe' Drug appeared first on Investor's Business Daily.
Shares of Agios Pharmaceuticals collapsed Monday on an unexpected side effect related to the company's thalassemia treatment, mitapivat.
The post Agios Crashes 19% After A Surprise Side Effect Hammered Its 'Very Safe' Drug appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
